Article Sidebar

PDF
Issue: No. 96 (2026): HỘI NGHỊ THƯỜNG NIÊN HỌC VIÊN, SINH VIÊN NGHIÊN CỨU KHOA HỌC LẦN THỨ VI NĂM 2026
Section: Article
DOI: 10.58490/ctjump.2026i96.4481
Date Published: 25/03/2026
Views 0
Downloads 0
How to Cite
Chau, T. D. T., & Nguyen, V. T. (2026). SARCOPENIA AND ITS ASSOCIATED FACTORS IN OLDER ADULTS WITH CHRONIC VIRAL HEPATITIS IN OUTPATIENT SETTINGS. Cantho Journal of Medicine and Pharmacy, 96, 8-15. https://doi.org/10.58490/ctjump.2026i96.4481

SARCOPENIA AND ITS ASSOCIATED FACTORS IN OLDER ADULTS WITH CHRONIC VIRAL HEPATITIS IN OUTPATIENT SETTINGS

Thi Diem Thanh Chau1, , Van Tan Nguyen2,3
1 Long An General Hospital, Long An
2 University of Medicine and Pharmacy at Ho Chi Minh City
3 Thong Nhat Hospital

Main Article Content

Abstract

Background: Sarcopenia is common among older adults, particularly in patients with chronic liver disease. Chronic inflammation, metabolic disturbances, and malnutrition associated with chronic viral hepatitis may contribute to reduced muscle mass and strength.  Objectives: This study aimed to determine the prevalence of sarcopenia and its associated factors among older outpatients with chronic viral hepatitis at Long An General Hospital in 2025. Materials and methods: A cross-sectional study was conducted among 406 patients aged ≥ 60 years with chronic viral hepatitis. Sarcopenia was diagnosed according to the 2019 Asian Working Group for Sarcopenia (AWGS 2019) criteria. Results: The mean age was 69 ± 6.8 years, and males accounted for 55.4% of the participants. The overall prevalence of sarcopenia was 28.8%. Multivariable logistic regression analysis showed that sarcopenia was associated with older age (OR = 1.2), longer disease duration (OR = 1.24), history of type 2 diabetes mellitus (OR = 12.3), smaller calf circumference (OR = 0.3), level of physical activity, and viral load (p ≤ 0.03). Conclusion: Sarcopenia is relatively common among older adults with chronic viral hepatitis. Early screening and appropriate interventions are essential to improve functional status and quality of life in this population.

Keywords

Sarcopenia, chronic viral hepatitis, older adults

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

References

1. Yuan S, Larsson SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism: clinical and experimental. 2023. 144, 155533. DOI:10.1016/j.metabol.2023.155533
2. Coelho MPP, de Castro P, de Vries TP, Colosimo EA, Bezerra JMT, et al. Sarcopenia in chronic viral hepatitis: From concept to clinical relevance. World journal of hepatology. 2023. 15(5), 649-665. DOI: 10.4254/wjh.v15.i5.649
3. Pham LT, Nguyen BT, Huynh DT, Nguyen BLT, Tran PN, et al. Community-based prevalence and associated factors of sarcopenia in the Vietnamese elderly. Sci Rep. 2024. 14(1), 17. DOI:10.1038/s41598-023-50979-4
4. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020. 21(3), 300-307.e2. DOI: 10.1016/j.jamda.2019.12.012
5. John, II, Kamlesh Kumar MJ, Koppath Parammal F, Abraham SE, Adem S, et al. Evaluating Sarcopenia Prevalence in Cirrhotic Patients and Its Association With Child-Turcotte-Pugh and MELD (Model for End-Stage Liver Disease) Scores: A Cross-Sectional Study. Cureus. 2025. 17(11), e97292. DOI: 10.7759/cureus.97292
6. Tuo S, Yeo YH, Chang R, Wen Z, Ran Q, et al. Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. Clinical Nutrition. 2024. 43(1), 84-94. DOI: https://doi.org/10.1016/j.clnu.2023.11.008
7. Xiao L, Dai M, Zhao F, Shen Y, Kwan RYC, et al. Assessing the risk factors associated with sarcopenia in patients with liver cirrhosis: a case–control study. Scientific Reports. 2023. 13(1), 21845. DOI: 10.1038/s41598-023-48955-z
8. He L, Luo G, Jiang H, Zhang l, Li Y, et al. Sarcopenia in type 2 diabetes mellitus: an imaging review. Frontiers in Medicine. 2026, 13. DOI:10.3389/fmed.2026.1637499
9. Chen H, Huang X, Dong M, Wen S, Zhou L, et al. The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy. Diabetes, metabolic syndrome and obesity : targets and therapy. 2023. 16, 1541-1554. DOI:10.2147/dmso.S410834
10. Rodrigues F, Domingos C, Monteiro D, Morouço P. A Review on Aging, Sarcopenia, Falls, and Resistance Training in Community-Dwelling Older Adults. International journal of environmental research and public health. 2022. 19(2). DOI:10.3390/ijerph19020874
11. Inoue T, Maeda K, Shimizu A, Nagano A, Ueshima J, et al. Calf circumference value for sarcopenia screening among older adults with stroke. Archives of gerontology and geriatrics. 2021. 93, 104290. DOI:10.1016/j.archger.2020.104290
12. Li W, Deng R, Luo Y, Li H, Chen F, et al. The effects of sarcopenia on the prognosis of patients with acute-on-chronic liver failure: a systematic review and meta-analysis. Systematic Review. 2025. 12. DOI:10.3389/fnut.2025.1649783
13. Mazeaud S, Zupo R, Couret A, Panza F, Sardone R, et al. Prevalence of Sarcopenia in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Clinical and translational gastroenterology. Jul 1 2023;14(7):e00584. DOI:10.14309/ctg.0000000000000584